General American Investors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,839,424
Closed -$4.07M 70
2023
Q2
$4.07M Sell
1,839,424
-75,000
-4% -$166K 0.35% 54
2023
Q1
$4.86M Buy
1,914,424
+30,031
+2% +$76.3K 0.46% 46
2022
Q4
$3.52M Sell
1,884,393
-31,706
-2% -$59.3K 0.34% 50
2022
Q3
$4.92M Buy
1,916,099
+163,629
+9% +$420K 0.51% 46
2022
Q2
$3.38M Buy
1,752,470
+304,300
+21% +$587K 0.34% 52
2022
Q1
$4.3M Buy
1,448,170
+141,251
+11% +$420K 0.35% 55
2021
Q4
$5.87M Buy
1,306,919
+194,261
+17% +$872K 0.46% 53
2021
Q3
$5.41M Buy
1,112,658
+71,461
+7% +$347K 0.46% 56
2021
Q2
$7.1M Buy
1,041,197
+54,602
+6% +$372K 0.59% 51
2021
Q1
$6.97M Sell
986,595
-14,156
-1% -$99.9K 0.65% 48
2020
Q4
$6.27M Hold
1,000,751
0.62% 47
2020
Q3
$5.41M Buy
1,000,751
+145,038
+17% +$785K 0.62% 45
2020
Q2
$4.47M Buy
855,713
+52,529
+7% +$274K 0.57% 45
2020
Q1
$2.53M Buy
803,184
+158,861
+25% +$500K 0.34% 50
2019
Q4
$2.6M Sell
644,323
-105,337
-14% -$425K 0.24% 60
2019
Q3
$3.24M Buy
749,660
+279,475
+59% +$1.21M 0.32% 56
2019
Q2
$1.88M Buy
470,185
+5,200
+1% +$20.7K 0.18% 66
2019
Q1
$2.49M Hold
464,985
0.25% 64
2018
Q4
$2.39M Buy
464,985
+28,621
+7% +$147K 0.25% 62
2018
Q3
$4.23M Buy
436,364
+50,000
+13% +$485K 0.36% 57
2018
Q2
$3.94M Buy
386,364
+77,500
+25% +$791K 0.36% 59
2018
Q1
$4.02M Hold
308,864
0.38% 59
2017
Q4
$5.53M Sell
308,864
-38,349
-11% -$686K 0.54% 51
2017
Q3
$8.72M Buy
347,213
+40,000
+13% +$1M 0.83% 46
2017
Q2
$7.4M Hold
307,213
0.75% 47
2017
Q1
$5.91M Buy
307,213
+44,037
+17% +$848K 0.58% 52
2016
Q4
$4.05M Sell
263,176
-277,076
-51% -$4.27M 0.41% 54
2016
Q3
$7.03M Buy
540,252
+63,176
+13% +$822K 0.72% 49
2016
Q2
$6.64M Buy
477,076
+200,000
+72% +$2.78M 0.69% 47
2016
Q1
$4.2M Hold
277,076
0.43% 49
2015
Q4
$5.26M Hold
277,076
0.48% 50
2015
Q3
$5.26M Hold
277,076
0.47% 50
2015
Q2
$7.14M Buy
277,076
+210,441
+316% +$5.42M 0.59% 50
2015
Q1
$2.08M Buy
+66,635
New +$2.08M 0.17% 57